An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

An Aspirin-Free Strategy for Immediate Treatment Following Complex Percutaneous Coronary Intervention

Published:2024-05 Issue:9 Volume:17 Page:1119-1130
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Yamamoto Ko^ORCID,Natsuaki Masahiro,Watanabe Hirotoshi^ORCID,Morimoto Takeshi^ORCID,Obayashi Yuki,Nishikawa Ryusuke^ORCID,Ando Kenji,Suwa Satoru,Isawa Tsuyoshi^ORCID,Takenaka Hiroyuki,Ishikawa Tetsuya,Tamura Toshihiro,Kawahatsu Kando,Hayashi Fujio,Akao Masaharu^ORCID,Serikawa Takeshi,Mori Hiroyoshi^ORCID,Kawamura Takayuki,Hagikura Arata,Shibata Naoki,Ono Koh,Kimura Takeshi,Ando Kenji,Suwa Satoru,Isawa Tsuyoshi,Takenaka Hiroyuki,Ishikawa Tetsuya,Wakabayashi Kohei,Onishi Yuko,Hibi Kiyoshi,Kawai Kazuya,Ono Koh,Yoshida Ruka,Suzuki Hiroshi,Nakazawa Gaku,Kusuyama Takanori,Morishima Itsuro,Tokuyama Hideo,Sakamoto Hiroki,Fujita Takanari,Nanasato Mamoru,Okayama Hideki,Tamura Toshihiro,Kawahatsu Kando,Hayashi Fujio,Akao Masaharu,Serikawa Takeshi,Kadota Kazushige,Hata Yoshiki,Akashi Yoshihiro J.,Matsuoka Shunzo,Tanaka Hiroyuki,Yamada Minoru,Wakatsuki Tetsuzo,Nozaki Yoichi,Kobayashi Yoshio,Kato Ryuichi,Ikari Yuji,Kurita Tairo,Kaitani Kazuaki,Sugimoto Atsuhiko,Ogata Nobuhiko,Yokomatsu Takafumi,Uehara Hiroki,Doijiri Tatsuki,Kozuma Ken,Nishida Yasunori,Yamaguchi Junichi,Morino Yoshihiro,Tanigawa Takashi,Nakano Yukiko,Makiguchi Noriko,Noda Toshiyuki,Shiode Nobuo,Abe Koji,Abe Shichiro,Tabuchi Isao,Ishihara Shozo,Kinoshita Makoto,Higuchi Motoaki,Takaya Tomofumi,Miura Shin-Ichiro,Tsubakimoto Yoshinori,Tsujita Kenichi,Kumagai Koji,Tanabe Kengo,Inoko Moriaki,Nakagami Takuo,Tomita Hirofumi,Nakano Masatsugu,Yumoto Kazuhiko,Wakeyama Takatoshi,Kaneko Takeo,Doi Masayuki

Publisher

Elsevier BV

Reference18 articles.

1. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

2. Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial;Watanabe;JAMA,2019

3. Effect of P2Y12 inhibitor monotherapy vs dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: the SMART-CHOICE randomized clinical trial;Hahn;JAMA,2019

4. Ticagrelor with or without aspirin in high-risk patients after PCI;Mehran;N Engl J Med,2019

5. Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO randomized clinical trial;Kim;JAMA,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dehydroevodiamine targeting IKKβ to alleviate acute gastric injury via inhibiting the p65/NLRP3 axis;Phytomedicine;2024-11

2. Antithrombotic Therapy in Patients with Complex Percutaneous Coronary Intervention and Cardiogenic Shock;Interventional Cardiology Clinics;2024-10

3. Aspirin-Free Strategies After Complex PCI;JACC: Cardiovascular Interventions;2024-05